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Fatty acid synthase (FAS) is altered in metabolic dis-
orders and cancer. Conventional FAS null mice die in
utero, so effects of whole-body inhibition of lipogen-
esis following development are unknown. Inducible
global knockout of FAS (iFASKO) in mice was lethal
due to a disrupted intestinal barrier and leukopenia.
Conditional loss of FAS was associated with the
selective suppression of granulopoiesis without
disrupting granulocytic differentiation. Transplanta-
tion of iFASKO bone marrow into wild-type mice
followed by Cre induction resulted in selective
neutrophil depletion, but not death. Impaired lipo-
genesis increased ER stress and apoptosis in
neutrophils by preferentially decreasing peroxi-
some-derived membrane phospholipids containing
ether bonds. Inducible global knockout of PexRAP,
a peroxisomal enzyme required for ether lipid synthe-
sis, also produced neutropenia. FAS knockdown in
neutrophil-like HL-60 cells caused cell loss that was
partially rescued by ether lipids. Inhibiting ether lipid
synthesis selectively constrains neutrophil develop-
ment, revealing an unrecognized pathway in immu-
nometabolism.
INTRODUCTION
De novo lipogenesis, the endogenous production of fats from
simple precursors, is altered in multiple diseases, including
obesity, diabetes, and cancer (Menendez and Lupu, 2007; Mor-
eno-Navarrete et al., 2009; Roberts et al., 2009). The multifunc-
tional enzyme fatty acid synthase (FAS) catalyzes the first
committed step in de novo lipogenesis. After priming with acetyl
coenzyme A (acetyl-CoA), FAS uses malonyl-CoA as a 2-carbon
source and NADPH as a cofactor to synthesize palmitate, a 16-
carbon saturated fatty acid. Mammalian FAS contains all of the
necessary enzymatic activities in a single polypeptide to convert
malonyl-CoA to palmitate. Although liver and adipose tissue areCthe two main sites of FAS-mediated lipogenesis, FAS is ubiqui-
tously expressed and regulated at transcriptional, as well as
posttranscriptional, levels. Insulin and glucose promote FAS
expression through the transcription factors SREBP1 and
ChREBPa, respectively (Jensen-Urstad and Semenkovich,
2012). FAS is also regulated by phosphorylation of distinct sub-
cellular pools of the protein (Jensen-Urstad et al., 2013).
A series of tissue-specific conditional knockout models of FAS
implicate this enzyme in integrative physiology. A common
theme in these studies is that FAS may channel newly synthe-
sized palmitate to specific subcellular compartments to transmit
signals relevant to metabolic disorders. In liver, brain, and mac-
rophages, FAS appears to be required for endogenous activa-
tion of the nuclear receptor PPARa (Chakravarthy et al., 2005,
2007, 2009; Schneider et al., 2010), a transcriptional regulator
of fatty acid oxidation and gluconeogenesis (Reddy and Hashi-
moto, 2001). In the endothelium and intestinal epithelium, FAS
provides substrate for palmitoylation of key proteins to maintain
tissue integrity (Wei et al., 2011, 2012). In cardiac and skeletal
muscle, FAS is required for calcium flux (Funai et al., 2013;
Razani et al., 2011). In neural tissues, FAS is important for
stem cell renewal (Knobloch et al., 2013). In adipose tissue,
FAS may be involved in the endogenous activation of PPARg,
a nuclear receptor critical for adipose tissue development and
function. Mice with adipose-specific deletion of FAS resist
diet-induced obesity and glucose intolerance and have
increased energy expenditure with browning of subcutaneous
white adipose tissue (Lodhi et al., 2012).
Given the diverse tissue-specific effects of FAS, it is difficult to
predict aggregate effects of whole-body FAS inhibition in an
adult, information relevant to pharmacologic strategies aimed
at inhibiting lipogenesis. The FAS null mutation induces embry-
onic lethality (Chirala et al., 2003), so mice with conventional
FAS deficiency have not been available. Here we describe
inducible global FAS knockout in adult mice. Unexpectedly,
these mice die from neutropenic sepsis soon after the knockout.
Neutropenia appears to result from increased programmed
cell death caused by impaired lipogenesis, which disrupted
membrane phospholipid composition, especially ether lipid
content. We also generated mice with inducible deficiency of
ether lipid synthesis and found neutropenia in the setting
of decreased membrane ether lipid content. These findingsell Metabolism 21, 51–64, January 6, 2015 ª2015 Elsevier Inc. 51
uncover a relationship between lipogenesis and inflammation
and establish a model for selective inactivation of the neutrophil
lineage.
RESULTS
Tamoxifen-Inducible Global Deletion of FAS in Adult
Mice Is Lethal
To avoid the embryonic lethality of the FAS null mutation, we
generated tamoxifen-inducible FAS knockout (iFASKO) mice
by crossing floxed FAS mice (FASlox/lox) with Rosa26-CreER
mice, transgenic mice expressing Cre recombinase fused to
the estrogen receptor ligand binding domain (CreER) under the
control of the ubiquitously expressed Rosa26 promoter (Fig-
ure S1A, available online) (Badea et al., 2003). Control (floxed
without Cre) and iFASKO mice were treated daily with tamoxifen
(50 mg/g body weight) for 5 consecutive days. FAS mRNA was
decreased in multiple tissues of tamoxifen-treated iFASKO
mice, including liver, kidney, and white adipose tissue, but not
in the hypothalamus (Figure S1B). Western blot analysis
confirmed that there was no knockout in the hypothalamus or
whole brain (Figure S1C), suggesting that phenotypes are not
likely due to direct CNS effects.
Following tamoxifen treatment, iFASKO mice abruptly lost
weight. By day 7, body weight was 30% lower (Figure 1A) in
the setting of a dramatic decrease in food and water intake (Fig-
ures 1B and 1C). Control mice manifested transient effects on
appetite with tamoxifen, as often seen with this agent, but
resumed normal food intake after treatment (Figure 1B). All
iFASKO mice died within 10 days of the initial tamoxifen dose
(Figure 1D). To determine if dietary lipids could compensate for
the lack of endogenously synthesized lipids, we fed a high-fat
diet to control and iFASKO mice for 4 weeks then administered
tamoxifen while continuing the high-fat diet. This dietary inter-
vention did not rescue iFASKO mice (Figure 1E), suggesting
that endogenously produced lipids have effects that cannot be
replaced by dietary lipids.
Gonadal white adipose tissue (WAT) depots in themutantmice
were strikingly decreased compared to those in control mice
(Figure 1F). MRI-determined body composition on day 7 after
tamoxifen treatment showed decreased adiposity and leanness
in the iFASKO mice treated with tamoxifen (Figure 1G).
PPARa is a ligand-activated nuclear receptor enriched in liver,
where it is important for fatty acid oxidation, ketogenesis, lipid
transport, and gluconeogenesis (Bernal-Mizrachi et al., 2003).
Consistent with previous studies suggesting that liver FAS regu-
lates endogenous activation of PPARa (Chakravarthy et al.,
2005), hepatic PPARa-dependent gene expression was
decreased in iFASKOmice, and mice had hepatic steatosis (Fig-
ures S2A–S2C). Serum chemistries are presented in Figures
S2D–S2G. Neither conditional FAS deficiency in liver nor
whole-body PPARa deficiency is associated with lethality.
Compromise of the Intestinal Barrier in iFASKOS Mice
Necropsies of iFASKOmice showed no gross lesions in the lung,
heart, brain, thymus, lymph nodes, adrenal, pituitary, middle ear,
or eye. However, epithelial cells in the colon were disordered at
the luminal border, suggesting compromise of the intestinal bar-
rier (Figure 2A).52 Cell Metabolism 21, 51–64, January 6, 2015 ª2015 Elsevier Inc.Restricting bacteria to the intestinal lumen maintains the
mutually beneficial relationship between mammalian host and
the intestinal microbiota (Hooper, 2009). A mucus barrier that
overlies the intestinal epithelium and is derived from goblet cells
provides this anatomical restriction. The large gel-forming pro-
tein Mucin 2 (Muc2), a key component of mucus (Johansson
et al., 2009), requires FAS-mediated de novo lipogenesis for
its palmitoylation and secretion. Mice with FAS inactivation
specifically in epithelial cells of the colon have a severe
disruption of the intestinal mucus barrier, increased intestinal
permeability, and systemic inflammation, resulting in reduced
viability (Wei et al., 2012). Alcian blue staining of goblet cells
and mucin revealed disruption of the mucus layer in iFASKO
mice (Figure 2B). Serum levels of bacterial endotoxin and the in-
flammatory cytokine tumor necrosis factor alpha (TNF-a) were
elevated in the knockout mice (Figures 2C and 2D). These re-
sults suggest that impaired intestinal barrier function allows
access of the intestinal microbiota to the circulation leading to
septicemia and death in iFASKO mice following Cre induction,
confirming our findings in mice with intestine-specific FAS inac-
tivation (Wei et al., 2012). Given the pleiotropic physiological
roles of FAS, it is also possible that other epithelial barriers
may be compromised with loss of FAS. As noted above,
there were no gross lesions in the lungs of these mice. Histo-
pathologic examination of lungs from necropsies showed no
evidence of pneumonitis and identified no significant lesions.
A few lung arterioles appeared to contain increased platelets,
but these small foci lacked the structure to allow identification
as thromboemboli. Representative photomicrographs from
lung are presented in Figure S2H.
A minority of intestine-specific FAS-deficient mice dies as
compared to the complete lethality in iFASKO mice, suggesting
involvement of an additional pathogenic mechanism.
FAS Knockout Disrupts Myelopoiesis
Despite abnormal intestinal architecture and systemic endotox-
emia, surprisingly there was no cellular inflammatory infiltrate in
the gut (Figure 2). Inflammatory cells were also sparse upon his-
tologic examination of blood vessels supplying multiple organs,
such as the liver and kidney (not shown). The lack of tissue neu-
trophils in tissues of septic mice suggested a potential defect in
the machinery of the inflammatory response, such as leuko-
cytes. Blood counts revealed 70% fewer white blood cells in
peripheral blood of iFASKO mice due primarily to the absence
of neutrophils (Figure 3A). Decreased T cells and a trend to
decreased monocytes were also observed. Red blood cell
counts were unaffected, but platelets were increased in the
mutant mice (Figure 3B).
Bone marrow is the primary site of granulopoiesis and serves
as a reservoir for mature neutrophils (Day and Link, 2012). The
bone marrow in iFASKO mice 7 days after the first injection of
tamoxifen (just prior to death) was hypocellular (Figure 3C). The
spleen is a major site of extramedullary hematopoiesis in the
setting of bone marrow failure. However, the spleen was smaller
and appeared necrotic in iFASKOmice (Figure 3D). Interestingly,
the serum level of granulocyte colony stimulating factor (G-CSF),
the principal cytokine regulating granulopoiesis that is often
induced in response to neutropenia (Liu et al., 1996), was
dramatically elevated in iFASKO mice (Figure 3E).
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Figure 1. Tamoxifen-Inducible FAS Knockout in Adult Mice Is Lethal
(A) Body weight of control and iFASKO mice before and after tamoxifen treatment.
(B) Food intake. Data are from five animals per genotype.
(C) Water intake on day 5 after tamoxifen treatment.
(D and E) Kaplan-Meier survival curves of control and iFASKO fed chow (D) or high-fat diet (E).
(F) Weight of gonadal white adipose tissue (WAT) in control and iFASKO mice treated with tamoxifen.
(G) MRI analysis of body composition of control and iFASKO mice before and after tamoxifen treatment.
In all panels, the mice were treated with tamoxifen for 5 days and analyzed on day 7 after the initial treatment, unless otherwise indicated. Data are expressed as
mean ± SEM of at least five animals per genotype. *p < 0.05; **p < 0.01; ***p < 0.001.To address potential mechanisms underlying the bonemarrow
phenotype, we treated mice with tamoxifen for 3 days followed
by analyses on day 4, a shorter course than the 5 days associ-Cated with complete loss of neutrophils, to allow us to study
neutrophils prior to their ablation. With this approach, gene
expression in marrow was notable for decreased FAS mRNA,ell Metabolism 21, 51–64, January 6, 2015 ª2015 Elsevier Inc. 53
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Figure 2. Tamoxifen-Inducible FAS Knock-
out Mice Have a Compromised Intestinal
Barrier
(A) Hematoxylin and eosin (H&E) staining of colon
from control and iFASKO mice.
(B) Alcian blue staining of goblet cells of the large
intestine in control and iFASKO mice.
(C) Serum endotoxin levels. Data are expressed
as mean ± SEM of 6–7 animals per genotype.
***p < 0.001.
(D) Serum TNF-a levels. **p < 0.01.
In all panels, the mice were treated with tamoxifen
for 5 days and analyzed on day 7 after the initial
treatment. Data are expressed as mean ± SEM of
3–5 animals per genotype.but there was no effect on the message for lymphoid enhancer-
binding factor 1 (LEF-1) (Figure S3), a transcription factor critical
for proliferation, survival, and differentiation of granulocyte pro-
genitor cells (Skokowa et al., 2006, 2012). There was also no
effect on message levels for the LEF-1 transcriptional target
C/EBPa or on expression of CD11b, LY9, or PPARg (Figure S3).
Expression of Flt3 (a tyrosine kinase involved in myeloid progen-
itor cell differentiation that is frequently mutated in leukemia) was
increased with FAS deficiency (Figure S3).
Using this abbreviated tamoxifen course, there was a striking
decrease in peripheral blood white blood cells, mostly due to
fewer mature neutrophils (Figure 4A). There was also a striking
loss of mature neutrophils in bone marrow (Figure 4B). Surpris-
ingly, a modest increase in B cells (B220) and T cells (CD3)
in the bone marrow was observed, suggesting a shift from
myelopoiesis to lymphopoiesis. The same analyses performed
in spleen showed a significant decrease in mature neutrophils
(not shown).
To determine whether terminal granulocytic differentiation
was altered in iFASKOmice, we assessed the frequency of gran-
ulocytic precursors in the bonemarrow (Figure 4C). Granulocytic
precursors can be classified based on the level of Gr-1 expres-
sion into early precursors (blasts and promyelocytes) and late54 Cell Metabolism 21, 51–64, January 6, 2015 ª2015 Elsevier Inc.precursors (myelocytes and metamyelo-
cytes) (Hestdal et al., 1991). Despite the
decrease in mature neutrophils, the num-
ber of early and late granulocytic precur-
sors in iFASKO mice was comparable to
that of control mice (Figure 4D).
We next asked whether the production
of myeloid progenitors was altered in
iFASKO mice. The number of myeloid
progenitors and multipotent progenitors
was assessed by flow cytometry (Fig-
ure 4E) as described (Akashi et al.,
2000). The number of granulocyte-
macrophage progenitors (GMPs) was
similar to that of control mice (Figure 4F).
Consistent with this observation, the
number of colony forming unit-granulo-
cyte/macrophage (CFU-GM) was similar
in iFASKO and control mice (Figure 4I).
Interestingly, a significant increase inmul-tipotent Kit+ Sca+ lineage (KSL) cells and a trend to increased
CD150+ KSL cells, which are highly enriched for hematopoietic
stem cells (Kiel et al., 2005), were observed in the bone marrow
of iFASKO mice. Collectively, these results suggest that the loss
of FAS specifically suppresses granulopoiesis, does not disrupt
terminal granulocytic differentiation, and is associated with
compensatory effects on myeloid progenitors.
Bone Marrow-Specific FAS Deletion Produces
Neutropenia without Lethality
We transplanted marrow from FASlox/lox/Rosa-Cre-ER+ or
FASlox/lox/Rosa-Cre-ER into lethally irradiated wild-type
C57BL/6J mice (Figure 5A) and allowed the mice to recover for
5 weeks before treating them with tamoxifen. White blood cell
counts were the same in mice 5 weeks before treating them
with tamoxifen. White blood cell counts were the same in mice
5 weeks after transplantation with floxed Fasn with or without
Rosa-Cre-ER (Figure 5B), and both groups of mice were
phenotypically normal. On day 7 after tamoxifen treatment,
white blood cells were significantly decreased in the mice that
received marrow from FASlox/lox/Rosa-Cre-ER+ donors (Fig-
ure 5C), a decrement due to near-complete loss of neutrophils.
There was no effect on lymphocyte counts in the transplanted
Control iFASKO
Bone marrow H&E stain
A B
C D E
Control iFASKO
Control iFASKO
0
200
400
600
800
1000
10000
12000
14000
16000
18000
20000
Se
ru
m
 G
-C
SF
 (p
g/
m
l)
***
*
**
**
*
WBC
Total WBC PMN Lymphocytes Monocytes
0
1
2
3
4
5
6
7
8
9
10
Control
iFASKO
C
el
ls
 x
 1
0-
6  p
er
 m
l
RBC
Control iFASKO
0
2
4
6
8
10
12
C
el
ls
 x
 1
0-
6  p
er
 m
l 
Platelets
Control iFASKO
0
250
500
750
1000
1250
1500
C
el
ls
 x
 1
0-
6  p
er
 m
l
Figure 3. FAS Knockout in Adult Mice Causes a Defect in Hematopoiesis
(A and B) Data are expressed as mean ± SEM of four animals per genotype. *p < 0.05; **p < 0.01.
(A) White blood cell (WBC) counts of peripheral blood from control and iFASKO mice.
(B) Red blood cell (RBC) and platelet counts of peripheral blood from control and iFASKO mice.
(C) H&E staining of bone marrow of control and iFASKO mice.
(D) Spleen from control and iFASKO mice.
(E) Serum G-CSF determination. Data are expressed as mean ± SEM of five animals per genotype. ***p < 0.0001.
In all panels, the mice were treated with tamoxifen for 5 days and analyzed on day 7 after the initial treatment.mice. These data suggest that loss of FAS in iFASKO mice pro-
duces a hematologic phenotype (Figure 3A) due to a cell-
autonomous loss of neutrophils but a non-cell-autonomous
loss of lymphocytes.
Despite neutropenia after tamoxifen treatment, bone marrow-
transplanted mice were viable (Figure 5D), indicating that death
in iFASKO mice was due to the combination of intestinal barrier
defects and neutropenia.
FAS Deficiency Causes Neutrophil Apoptosis and ER
Stress
To address the mechanism underlying the cell-autonomous
neutrophil effect, we isolated marrow following the abbreviated
tamoxifen course, removed red blood cells, and stained residual
cells with a cocktail of antibodies to distinguish progenitor cells
from differentiated cells. Cells that do not bind to these anti-
bodies correspond to lineage-negative cells. Staining with
annexin V-FITC to assess apoptosis followed by flow cytometry
indicated that FAS deficiency caused cell death mainly in differ-
entiated (mature) cells (Figure 6A).
Staining Gr-1 and Cd11b-positive bone marrow cells with
annexin V-FITC and propidium iodide showed that apoptosis
was increased in iFASKO neutrophils (Figure 6B), an observationCconfirmed by TUNEL staining (Figure 6C). Apoptosis is often
associatedwith endoplasmic reticulum (ER) stress; the ER stress
markers CHOP andGrp78were increased in iFASKO neutrophils
(Figure 6D). ER stress can be associatedwith alterations inmem-
brane phospholipids, and lipidomic characterization of neutro-
phil membranes showed that numerous phosphatidylcholine
(PC) species were decreased in iFASKO neutrophils (Figure 6E).
Six of the ten PC species that were decreased in iFASKO mem-
branes were ether lipids, characterized by an ether bond instead
of an ester bond at the sn-1 position. Phosphatidylethanolamine
species were minimally affected (Figure 6F); total PC and PE
mass values are shown in Figure 6G.
We also performed analyses to address the possibility that
FAS deficiency affects other lipids in neutrophils. Plasmalogens
were scarce, but one of the ether-linked phospholipids (16:0e/
20:4-GPC, indicated by an arrow) shown in Figure 6E had a dou-
ble bond adjacent to the ether bond at the sn-1 position indica-
tive of a plasmalogen. This species was significantly decreased
in iFASKO neutrophils. Platelet activating factor was not de-
tected (not shown). Ceramides were also scarce, but the relative
abundance of four ceramide species (d18:1/16:0, d18:1/24:2,
d18:1/24:1, and d18:1/24:0) was significantly increased in
iFASKO neutrophils compared to that of control neutrophilsell Metabolism 21, 51–64, January 6, 2015 ª2015 Elsevier Inc. 55
Figure 4. Loss of FAS Impairs Granulopoiesis but Does Not Disrupt Terminal Differentiation or Production of Myeloid Progenitors
(A and B) Blood count analysis of peripheral blood (A) and bone marrow (B). The number of white blood cells, (WBC), B cells (B220), T cells (CD3), neutrophils
(Gr1hi), and monocytes (CD115) is shown. Data are expressed as mean ± SEM of four animals per genotype. *p < 0.05; **p < 0.01.
(C) Representative dot plots showing Gr-1 and CD11b staining of bone marrow cells; data are gated on B220, CD3, and CD115 cells. Mature neutrophils (top
gate) are identified as Gr1hi cells, late granulocytic precursors as Gr1Int cells (middle gate), and early granulocytic precursors as Gr1low cells (lower gate).
(D) Number of mature neutrophils or granulocytic precursors in the bone marrow. Data are expressed as mean ± SEM of 4–5 mice. ***p < 0.001.
(E) Representative dot plots showing the gating strategy to identify granulocyte-macrophage progenitors (GMPs), Kit+ Sca+ lineage (KSL) cells, or CD150+ KSL
cells.
(F–I) Analyses for granulocyte-macrophage progenitors (GMPs) (F), multipotent Kit+ Sca+ lin (KSL) cells (G), CD150+ KSL cells (H), and colony forming unit-
granulocyte/macrophage (CFU-GM) cells (I). Data are expressed as mean ± SEM of 4–5 mice. **p < 0.01.
In all panels, the mice were treated with tamoxifen for 3 days and analyzed on day 4.
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Figure 5. Bone Marrow-Restricted FAS
Knockout Causes Neutropenia, but Not
Lethality
(A) Schematic diagram of bone marrow transplant
experiment. The recipient mice were allowed to
recover for 5 weeks and then treated with tamox-
ifen for 5 days.
(B) Total white blood cell count in mice that
received marrow from Cre or Cre+ donor mice
prior to tamoxifen treatment.
(C) Total and differential white blood cell count in
bone marrow transplant mice after tamoxifen
treatment. Data are expressed as mean ± SEM of
five animals per genotype. *p < 0.05; **p < 0.01.
(D) Kaplan-Meier survival curve of bone marrow
transplant mice.(Table S1), perhaps reflecting the induction of apoptosis occur-
ring in these cells.
Lipidomic characterization of monocytes studied under the
same conditions of induced FAS deficiency showed that while
overall ether lipid abundance was low, several ether lipid spe-
cies, all phosphatidylcholines, were significantly decreased
(Table S2). Monocyte counts were not significantly decreased
in iFASKO mice, but additional studies focused on monocyte
biologywould be required to determine if promotion of apoptosis
associated with these lipid changes occurs only within the
context of granulocytes.
Generation of Mice with Inducible Knockdown of
PexRAP, the Terminal Enzyme in Ether Lipid Synthesis
Ether lipids are synthesized in peroxisomes (Lodhi andSemenko-
vich, 2014), and we recently identified PexRAP (peroxisomal
reductase activating PPAR) as the gene encoding the enzyme
responsible for the terminal step in ether lipid synthesis (Lodhi
et al., 2012). Since ether lipidswere decreased in iFASKOneutro-
phils during the process of cell loss, we generated a unique
mousemodel to test thehypothesis that theneutrophil phenotype
was ether lipid dependent. We floxed the PexRAP (Dhrs7b) locus
inmiceusing the strategydepicted inFigure 7A,with results of the
PCRassay for genotyping heterozygous and homozygous floxed
animals shown in Figure 7B. Floxed PexRAP mice were crossed
with Rosa26-CreER mice to create PexRAP-iKO mice, and ani-
mals were treated with tamoxifen to induce Cre. Rearrangement
at the PexRAP locus was confirmed (Figure 7C), and PexRAP
expression was decreased in liver and bone marrow following
tamoxifen (Figure 7D). Figure 7E shows representative spectra
of phosphatidylcholine species from thebonemarrow leukocytes
of control and PexRAP-iKO mice with ether lipids labeled in red.
Quantitation of these results (Figure 7F) demonstrated decreasesCell Metabolism 21, 51–in several ether lipid species as well as in-
creases in acyl lipid species, perhaps re-
flecting compensation for ether lipid loss.
Thus, PexRAP inhibition is associated
with decreased leukocyte ether lipid con-
tent, the expected biochemical conse-
quences of this knockout.
Adult PexRAP-iKOmicewereviable and
had leukopenia predominantly due to thenearly complete loss of neutrophils (Figure 7G). There were also
modest effects on lymphocytes, similar to iFASKO mice, and a
small decrease in erythrocytes, but not platelets (Figure S4).
Systemic activation of CreER alone using high doses of
tamoxifen may cause hematologic toxicity characterized by se-
vere anemia, a reduction in B cells, preferential effects on imma-
ture lineage cells, and no effect on myeloid cells (Higashi et al.,
2009). Lower doses of tamoxifen (like those used in our experi-
ments) are not associated with this effect (Higashi et al., 2009;
Uhmann et al., 2009). In iFASKO mice, there was no anemia,
an increase in B cell precursors, preferential effects on mature
myeloid cells, and severe loss of myeloid cells, all different
from effects of Cre alone. PexRAP-iKO mice (floxed at both
PexRAP alleles) also showed severe loss of myeloid cells. We
generated heterozygous floxed PexRAP mice in the presence
or absence of CreER and treated all with tamoxifen. There was
no significant difference in hematologic parameters for these
mice (Table S3), suggesting that severe neutropenia in FAS
knockout and PexRAP knockout animals is not due to Cre alone.
There was a trend suggesting a gene dosage effect, consistent
with a critical role for ether lipid synthesis in neutrophil biology.
WhenHL-60cells, a cell linewithneutrophil-like characteristics,
were treated with a lentivirus to induce FAS knockdown, viability
was compromised (Figure 7H, solid bar). Confirmation of the
knockdown is shown in Figure 7I. When the FAS knockdown
was performed in the presence of a mixture of 16:0 and 18:0 alkyl
glycerol (a substrate for synthesis of ether-phosphatidylcholine
species), this adverse effect on viability was partially rescued.
DISCUSSION
Our findings suggest that global deletion of FAS in adult mice
causes death due to systemic endotoxemia in the setting of64, January 6, 2015 ª2015 Elsevier Inc. 57
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Figure 6. FAS Knockout Causes Neutrophil Apoptosis and ER Stress and Preferentially Decreases Membrane Ether-Linked Glycerophos-
phocholines
(A) Following removal of red blood cells, the remaining cells were stained with a cocktail of antibodies that recognize differentiated cells in the marrow and then
stained with annexin V and analyzed by FACScan.
(B) Cells were stained with neutrophil makers Gr-1 andCd11b and then stainedwith annexin V and propidium and analyzed by FACScan. Data represent 5–6mice
per genotype. *p < 0.05.
(legend continued on next page)
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compromised intestinal barrier function and neutropenia. Neu-
tropenia appears to result from increased ER stress and
apoptosis caused by a preferential effect on the membrane con-
tent of peroxisome-derived ether lipids. A model depicting this
lipogenic pathway is shown in Figure 7J. These results establish
an unrecognized link between endogenous lipid metabolism and
inflammation and provide proof of principle for inhibiting lipogen-
esis to selectively disrupt neutrophils.
Neutrophils defend against invading bacteria that have cir-
cumvented physical barriers provided by epithelial surfaces.
Signaling molecules released by microorganisms activate blood
vessel endothelial cells, which capture neutrophils and guide
them into tissues (Borregaard, 2010). Factors produced by bac-
teria, such as the peptide N-formyl-methionine-leucine-phenyl-
alanine (fMLP), serve as chemotactic signals for recruitment of
neutrophils, which defend the host through phagocytosis,
release of bactericidal substances, and neutrophil extracellular
traps, networks of DNA webs secreted by neutrophils that trap
and kill invading bacteria (Borregaard, 2010).
FAS deficiency is associated with a marked and specific
defect in granulopoiesis. The number of myeloid progenitors in
the bonemarrow of iFASKOmice is comparable to that of control
mice, indicating that the commitment to the myeloid lineage is
not affected by FAS deficiency. Notably, the increase in multipo-
tent progenitors (i.e., KSL cells) is likely secondary, at least in
part, to the high systemic level of G-CSF (Schuettpelz et al.,
2014). The normal number of granulocytic precursors in the
bonemarrow of iFASKOmice also indicates that FAS is dispens-
able for granulocytic differentiation. However, FAS is required for
maintenance of mature neutrophils, and FAS deficiency is asso-
ciated with increased neutrophil apoptosis. The bone marrow
chimera studies show that this is mediated in a cell-intrinsic
fashion. These data raise the possibility that altered lipid meta-
bolism renders FAS-deficient neutrophils more susceptible to
apoptosis. Consistent with this possibility, the neutrophil
membrane composition is markedly altered in iFASKO mice.
Specifically, peroxisome-derived ether-linked phospholipids
are selectively decreased in FAS-deficient neutrophils. Notably,
perturbation of cellular phospholipid composition influences
membrane integrity (Li et al., 2006), activates ER stress (Fu
et al., 2011; Volmer et al., 2013), and increases apoptosis (Yen
et al., 1999).
FAS associates with peroxisomes, organelles important in
lipid metabolism (Lodhi and Semenkovich, 2014). FAS is
involved in generating ether-linked glycerophosphocholines
that may be endogenous ligands for the nuclear receptor PPARg
in adipocytes, and FAS is enriched in adipocyte peroxisome
fractions (Lodhi et al., 2012). FAS interacts with PMP70, a perox-
isomal membrane protein involved in fatty acyl CoA transport
into peroxisomes (Hillebrand et al., 2012), directly linking FAS(C) TUNEL staining of neutrophils from control and iFASKO mice.
(D) Western blot analysis of neutrophils from control and iFASKO mice.
(E–G) Determination of individual species for phosphatidylcholine (PC) (E), individ
PE (G). Control and iFASKO mice were treated with tamoxifen for 3 days, and bo
neutrophils were harvested by negative selection. Phospholipid composition w
by ‘‘e,’’ and the single plasmalogen identified is indicated by the arrow in (E). Data a
per genotype. *p < 0.05.
Control and iFASKO mice were treated with tamoxifen for 3 days, and bone mar
Cto peroxisome lipid metabolism. Collectively, these results sug-
gest that FAS channels fatty acids to peroxisomes for ether lipid
synthesis.
Ether phospholipids carry an alkyl group attached to glycerol
at the sn-1 position by an ether bond as opposed to the ester
bond present in conventional phospholipids. Ether lipid synthe-
sis requires the dihydroxyacetone phosphate pathway (Hajra,
1995). The terminal step in the dihydroxyacetone pathway is car-
ried out at the peroxisomal membrane by a reductase activity
purified four decades ago (LaBelle and Hajra, 1974). We identi-
fied the gene encoding the protein responsible for this reductase
activity as PexRAP (Lodhi et al., 2012). In the current work, we
show that tamoxifen-inducible knockout of PexRAP reduces
ether-linked lipids and results in neutrophil loss, phenocopying
the results obtained with FAS deletion. Thus, it is likely that the
FAS/PexRAP axis maintains membrane lipid composition and
viability in neutrophils.
Ether lipids are scarce in most tissues, but curiously nearly half
of the phosphatidylcholine pool in neutrophils is in the alkyl ether
form (Bra¨utigam et al., 1996; Mueller et al., 1982, 1984). The role
of ether lipids in this cell type is unclear, but intracellular signaling
is a possibility. Activation of neutrophils with fMLP increases di-
acylglycerol (DAG) as well as the ether lipid equivalent of DAG,
1-O-alkyl-2-acylglycerol (AAG). AAG production lags behind
that of DAG (Dougherty et al., 1989). Since AAG inhibits DAG-
mediated protein kinase C (PKC) activation (Bass et al., 1988),
AAG induction may dampen the PKC-mediated respiratory burst
in neutrophils. Ether lipids may also affect physical properties to
regulate neutrophil function (Nagan and Zoeller, 2001).
Neutrophils are a vital component of innate immunity, but their
hyperactivation or overproduction is detrimental. Reactive oxy-
gen species and other mediators secreted by neutrophils kill
pathogens but can also damage surrounding tissues. In rheuma-
toid arthritis, hyperactive neutrophils contribute to joint damage
(Kaplan, 2013). In diet-induced obesity, neutrophils infiltrate
tissues where their secretion of proteases promotes insulin
resistance through degradation of insulin receptor substrate 1
(Talukdar et al., 2012). Treatment of human leukemia cells with
an FAS inhibitor promotes apoptosis (Samudio et al., 2010),
similar to the effects we observe in neutrophils with genetic inhi-
bition of FAS or PexRAP. These findings suggest that targeted
inhibition of lipogenic enzymes could alter the course of neutro-
phil-associated diseases.EXPERIMENTAL PROCEDURES
Animals
To generate tamoxifen-inducible global FAS knockout (iFASKO) mice, floxed
FAS (FASlox/lox) mice (Chakravarthy et al., 2005) were crossed with Rosa26-
CreER mice (Badea et al., 2003) obtained from The Jackson Laboratory. Toual species for phosphatidylethanolamine (PE) (F), and total content of PC and
ne marrow was harvested on day 4. Following removal of red blood cells, the
as analyzed by mass spectrometry. Ether-linked phospholipids are denoted
remean ± SD of duplicate determinations using pooled extracts from four mice
row was harvested on day 4.
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induce Cre expression, iFASKO mice were treated with 50 mg/g body weight
tamoxifen by intraperitoneal injection for five consecutive days as described
(Remedi et al., 2009).
To generatemice with a floxed PexRAP allele (encoded byDhrs7b), a target-
ing vector for conditional knockout (design ID 39122) was obtained from the
EUCOMM Repository. The targeting vector was generated by flanking a crit-
ical exon common to two known transcript variants of Dhrs7b (i.e., exon 3 in
the longer variant) with loxP sites such that following Cre-mediated deletion,
a frameshift is created, resulting in nonsense-mediated decay of the message.
The vector was linearized and electroporated into C57BL/6 embryonic stem
cells (ESCs). Out of 144 clones screened, 20 were properly targeted. One
clone (C26) that had a normal karyotype was selected for microinjection into
B6(Cg)-Tyrc-2J/J blastocyts to generate chimeric mice. Highly chimeric
mice were bred with B6(Cg)-Tyrc-2J/J females to select for germline transmis-
sion. To remove the neomycin selection cassette, the mice were first crossed
with transgenicmice expressing Flp recombinase under the control of the actin
promoter (The Jackson Laboratory). The Flp transgene was removed by
crossing the mice with wild-type C57BL6/J mice. The mice were then crossed
with Rosa26-CreER mice to generate PexRAP-iKO mice. Rosa26-CreER was
induced with tamoxifen as described above for iFASKO mice.
Genotyping of iFASKO was performed using previously described primer
sets (Chakravarthy et al., 2005). Floxed PexRAP mice were genotyped
using primers P1 (50-GAA-CTG-TGT-GTG-TGT-ATC-TGC-CAG-T-30) and P2
(50-TCA-ACT-CTG-CTG-TAG-TGG-AGC-AAG-30). To confirm Cre-mediated
recombination in floxed PexRAP mice, primers P1 and P3 (50-CTT- CTG-
GTG-TGT-CTG-AAG-ACA-ATG-30) were used. Diets included Purina 4043
control chow and Harlan Teklad TD 88137 high-fat diet. Unless indicated
otherwise, male iFASKO or PexRAP-iKO mice and respective control litter-
mates at 8–12 weeks of age were used for experiments. The Washington
University Animal Studies Committee approved animal protocols.
Complete Blood Counts
Peripheral blood from control and FAS or PexRAP knockout mice was
collected into EDTA-coated tubes and analyzed in the Washington University
Division of Comparative Medicine Research Animal Diagnostic Laboratory
where automated complete and differential blood counts were performed.
Trained technicians manually confirmed differential cell counts.
Flow Cytometry
Blood, bone marrow, and spleen cells were harvested from mice using stan-
dard techniques, and the number of nucleated cells in these tissues was quan-
tified using a Hemavet (Drew Scientific) or Cellometer Auto 2000 (Nexcelom)
cell counter. Mononuclear cell preparations were lysed in Tris-buffered ammo-
nium chloride buffer (pH 7.2) and incubated with the indicated antibody at 4C
for 45 min in PBS containing 0.1% sodium azide, 1 mM EDTA, and 0.2% (w/v)
BSA to block nonspecific binding. For lineage analysis, the following directly
conjugated monoclonal antibodies were used (all from eBioscience): APC-
e780 Gr1 (RB6-8C5), APC B220 (RA3-6B2), PE CD115 (AFS98,), FITC
CD11b (M1/70), and PerCP-Cy5.5 CD3 (145-2C11). Hematopoietic progeni-Figure 7. Tamoxifen-Inducible Knockout of the Ether Lipid Synthetic En
in HL-60 Cells Partially Rescues Cell Loss
(A) Targeting strategy for generation of PexRAP conditional knockout mice.
(B) Genotyping of PexRAP homozygous floxed, heterozygous floxed, and wild-ty
(C) Confirmation of Cre-mediated recombination by PCR using primers P1 and P
(D) Real-time PCR analysis of mRNA expression in liver and bone marrow of m
expressed as mean ± SEM of three mice per genotype. *p < 0.05; **p < 0.001.
(E) Representative mass spectra of GPCs from bone marrow white blood cells
described in (D). Ether-linked GPCs are indicated in red.
(F) Quantification of relative abundance of GPCs. Data represent mean ± SD of d
(G) Peripheral blood count analysis of control and PexRAP-iKO mice. The mice w
on day 7. Data are mean ± SEM of four animals per genotype. **p < 0.001.
(H) Effect of alkyl glycerol (AG) supplementation viability of HL-60 cells treated w
determinations. *p < 0.05 versus SC; #p < 0.05 versus KD.
(I) Western blot of FAS knockdown in HL-60 cells.
(J) Proposed model of the role of lipogenesis in maintaining viability and membran
phosphate; PMP70, peroxisomal membrane protein of 70 kD.
Ctors were quantified as described (Akashi et al., 2000) using the following
antibodies: PE-Cy7 CD3, B220, Gr-1, Terr119 (TER-119), APC e780 C-Kit
(ACK2), APC Flt3 (A2F10), FITC CD34 (RAM34), PerCP-Cy5.5 Sca-1(D7),
and BVe450 CD16/32 (93). All cells were analyzed using a FACScan flow
cytometer (Becton Dickinson). Apoptosis assays used amouse hematopoietic
progenitor cell enrichment set consisting of biotin-conjugated monoclonal
antibodies against CD3e, Cd11b, CD45R, Ly6G/Ly6C, and TER-119 from
BD Pharmingen.
Apoptosis Assays
Apoptosis wasmeasured by flow cytometry using the TACSAnnexin V kit (Tre-
vigen) as described by the manufacturer. FITC-Annexin V fluorescence was
read with the FL1 photomultiplier tube, and propidium iodide (PI) fluorescence
was detected using the FL3 channel. Apoptosis was also assessed using the
TUNEL Apoptosis Detection kit (Millipore) as described by the manufacturer.
CFU-C Assays
Bone marrow cells (5.0 3 104) were plated in 3 ml of methylcellulose media
supplemented with a cocktail of recombinant cytokines (MethoCult 3434;
StemCell Technologies). Cultures were plated in duplicate and placed in a
humidified chamber with 5% CO2 at 37
C. After 7 days of culture, the number
of colonies per dish was counted.
Quantitative Real-Time PCR
Total RNAwas extracted using RNeasy Lipid Tissue kit (QIAGEN) or the TRIzol
reagent (Invitrogen) and reverse transcribed using iScript cDNA Synthesis kit
(Bio-Rad). Quantitative PCR was performed with an ABI Prism 7700 PCR in-
strument using SYBR Green reagent (Applied Biosystems). Prevalidated
primers spanning exon-exon boundaries were used for amplifications. Primer
sequences are available upon request. Assays were performed in duplicate,
and results were normalized to ribosomal protein L32 mRNA levels, which
were unaffected by genotype or intervention.
Analytical Procedures
Serum triglycerides, cholesterol, free fatty acids (FFAs), and glucose were as-
sayed in mice following a 4 hr fast. Triglyceride and cholesterol levels were
determined using reagents from Thermo Scientific. FFA levels were assayed
using reagents provided by Wako Chemicals. Serum glucose was measured
using reagents from Sigma. G-CSF was measured using a Quantikine ELISA
fromR&DSystems. Bacterial endotoxin wasmeasured using a limulus amebo-
cyte lysate assay (Wei et al., 2012). Body composition was determined using
an EchoMRI 3-in-1 instrument (Echo Medical Systems). Western blotting
was performed using a rabbit polyclonal anti-FAS antibody from Abcam, an
anti-actin antibody from Sigma, and antibodies against CHOP and Grp78
from Cell Signaling.
Bone Marrow Transplantation
Bone marrow was harvested from the femurs and tibias of 12-week-old non-
tamoxifen-treated iFASKO or control (floxed but without Cre) mice by flushingzymePexRAPCauses Neutropenia, and Ether Lipid Supplementation
pe mice by PCR using primers P1 and P2 and tail DNA.
3 in livers of mice treated with tamoxifen.
ice on day 5 after four consecutive daily treatments with tamoxifen. Data are
of control and PexRAP-iKO mice. The mice were treated with tamoxifen as
uplicate determinations in three mice per genotype. *p < 0.05; **p < 0.001.
ere treated with tamoxifen for 5 consecutive days, and the blood was collected
ith scrambled (control) or FAS shRNA. Data are mean ± SEM of three separate
e integrity in neutrophils. ACS, acyl-CoA synthetase; DHAP, dihydroxyacetone
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bones with cold PBS. Marrow was washed, triturated using a 24G needle,
collected by centrifugation at 1250 rpm for 4 min, and diluted with PBS. After
lysis of erythrocytes using 1X RBX Lysis Buffer (eBioscience), cells were
counted to obtain a defined concentration of unfractionated bone marrow.
Recipient wild-type C57BL/6 mice were lethally irradiated with 10 Gy from a
cesium-137 g-cell irradiator and infused with 5 3 106 donor marrow cells
within 6 hr of irradiation. The fidelity of the process was confirmed by verifying
the lethality of the radiation dose in animals not reconstituted with marrow and
by histological staining of recipient femurs. At 6 weeks after transplantation,
the mice were treated with tamoxifen as described above. Complete blood
count analysis was conducted prior to and after tamoxifen treatment.
Neutrophil Isolation
Mouse bone marrow was collected from femurs and tibias as described
above. Following lysis of red blood cells, neutrophils were isolated by nega-
tive selection using the EasySep Mouse Neutrophil Enrichment kit (Stem
Cell Technology) as described by the manufacturer. Isolation of neutrophils
was confirmed by positive staining for both Gr-1 and Cd11b using flow
cytometry.
Cell Culture
HL-60 cells were maintained in Iscove’s modified Dulbecco’s medium (IMDM)
supplemented with 20% FBS. Human embryonic kidney 293T (HEK293T) cells
were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% FBS.
Ether Lipid Supplementation in FAS Knockdown HL-60 Cells
Lentiviral FAS or scrambled shRNA was generated in 293T cells as previously
described (Lodhi et al., 2012) and used to treat 5 3 106 HL-60 cells together
with a cocktail containing 5 mM each of 1-O-octadecyl-rac-glycerol
(18:0-AG) and 1-O-hexadecyl-rac-glycerol (16:0-AG) or vehicle (ethanol). After
48 hr, cells were treatedwith freshmedia containing alkyl glycerol and puromy-
cin. The cells were maintained under these conditions for an additional 72 hr
with media replaced every day. Cell viability was determined using the
CellTiter96 assay (Promega) as described by the manufacturer.
Mass Spectrometry
Low-energy CAD tandem mass spectrometry was conducted on a Thermo
Scientific TSQ Vantage Triple Stage Quadrupole mass spectrometer equipped
with Xcalibur operating system. Methanol/chloroform (3/1, v/v, with 0.3%
NH4OH) was continuously infused into the ESI source with a syringe pump
at a flow rate of 10 ml/min, and lipid extracts (with 14:0/14:0-PC and
14:0/14:0-PE internal standards added) dissolved in methanol/chloroform
(3/1, v/v) were loop injected. The skimmer of the ESI source was at ground
potential, and the electrospray needle was set at 3.0 kV. The temperature of
the heated capillary was 280C. Q1 and Q3 quadrupole resolution was tuned
to 0.7 Da (half width). The PC species in the total lipid extract was detected as
[M + H]+ ions by precursor ion scanning of m/z 184, while PE species were
detected as [M + H]+ ions by neutral loss scanning of 141 (Bru¨gger et al.,
1997). The collision energy was set at 30 eV, and the argon target gas was
set at 1.0 mTorr. The tandem mass spectra were acquired by scanning from
m/z 630 to m/z 850 at a rate of 2 s per scan. The mass spectra were acquired
in profile mode, and the final spectra represented the average of 40 spectra
accumulated for 1 to 2 min.
Structural assignments of the glycerophospholipid species in lipid extracts
were conducted on a Thermo Scientific linear ion trap (LIT) LTQ Orbitrap Velos
mass spectrometer as described (Hsu et al., 2014).
Statistical Analysis
Comparisons between two groups were performed using an unpaired two-
tailed t test. ANOVA was used for more than two groups, and post testing
was performed using Tukey’s posttest.
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